Related Experiment Video
Updated: May 22, 2026

Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Analyzing longitudinal antidiabetic medication patterns: a data-driven clustering framework
Peng Zhang1, Jennifer Mason Lobo2, Min-Woong Sohn3
1Department of Health and Kinesiology, College of Applied Health Sciences, University of Illinois at Urbana-Champaign, 2005 Huff Hall 1206 S Fourth Street, Champaign, IL, 61820, USA.
Researchers identified distinct long-term antidiabetic medication use patterns in Medicare beneficiaries. Understanding these trajectories, including disparities in discontinuation and intensification, can improve diabetes care.
Area of Science:
- Diabetes management
- Pharmacotherapy research
- Health services research
Background:
- Glycemic control is crucial for preventing diabetes complications.
- Long-term antidiabetic medication use patterns are not well understood.
- This study addresses gaps in knowledge regarding medication trajectories.
Purpose of the Study:
- To identify common antidiabetic medication use patterns in Medicare beneficiaries.
- To analyze demographic and clinical characteristics across identified patient clusters.
- To understand long-term treatment pathways for diabetes management.
Main Methods:
- Retrospective cohort study of Medicare beneficiaries initiating metformin.
- Defined medication transitions: switch, intensification, de-intensification, discontinuation, re-initiation.
- Applied dynamic time warping and Partitioning Around Medoids clustering to analyze medication sequences.
Main Results:
- Identified 222 distinct medication patterns, grouped into five clusters.
- Most common patterns: continuous metformin, recurrent discontinuation/re-initiation, single discontinuation.
- Disparities noted: Non-Hispanic Black patients more likely to discontinue; females more likely to intensify.
Conclusions:
- Sequence analysis and clustering reveal complex medication use patterns.
- Understanding treatment trajectories and disparities is key for improving adherence.
- Findings support data-driven decisions for equitable diabetes care.
Related Concept Videos
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Analysis of Population Pharmacokinetic Data
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...